Brief: Hemcheck Sweden Q4 Pre-Tax Loss Widens To SEK 3.5 Million

Bio Vitos Pharma AB

14/02/2022 09:42

Feb 14 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * Q4 PRE-TAX LOSS SEK 3.5 MILLION VERSUS LOSS SEK 3.1
MILLION YEAR
AGO
    * THE BOARD PROPOSES THAT NO DIVIDEND BE PAID FOR 2021
    * Q4 OPERATING INCOME AMOUNTED TO SEK 180,000 (142,000)

Source text for Eikon:  ID:nWkr5yV9Bw 
Further company coverage:  HEMC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))